Navigation Links
Khannna Institute to offer Crystalens in Quarter Diopter Steps
Date:5/28/2010

Khanna Institute will adopt the new range of crystalens to benfit the patients.

(Vocus) -- Dr. Khanna and crystal lens have had a symbiotic relationship to advance vision in people suffering from presbyopia or cataracts. Crystalens has especially been helpful in people who have undergone radial RK or macular degeneration. The Crystalens is the only FDA approved accommodating intraocular lens in the United States. As the accuracy of the surgery in the lens has increased lenses in intermediate powers were desired. Bausch & Lomb has therefore introduced Crystalens OA and Crystalens HD in quarter diopter steps. Crystalens OA and HD are the fifth generation of Crystalens. Crystalens remains the only presbyopic channel lens available in quarter diopter steps.

Approximately 3 million cataract surgeries are performed in the U.S. every year. A cataract is a clouding on the normally clear lens in the eye. When a cataract forms, the natural lens in the patient’s eye can be replaced by an intraocular lens. Balanced billing was introduced which allows patients to pay out of pocket to upgrade to premium lenses.

The research also indicates that a number of patients are willing to pay a little extra money in order to get the best quality vision. Prelex is presbyopic refractive lens exchange that is the dysfunctional natural lens is removed and exchanged for a presbyopic channel lens.

Crystalens is the only FDA-approved accommodating intraocular lens. Unlike the standard cataract replacement lenses, Crystalens is designed to not only eliminate the patient’s cataract but also to give patients full range of vision so that they can see near, far and everything in between. Many Crystalens patients hardly, if ever, need to wear their glasses or contacts again.

Dr. Rajesh Khanna is a Los Angeles LASIK and Refractive Cataract surgeon with offices in Los Angeles and Beverly Hills. He is the founder and medical director of The Khanna Institute of Lasik and Refractive Surgery. Dr. Khanna has been voted as the best LASIK surgeon by popular choice, by the readers of Los Angeles daily news and the Ventura County Star. Dr. Khanna has performed vision enhancements on many celebrities and athletes alike. Those we are able disclose include actor Corbin Blue from High School Musical, Disney channel star Brenda Song, Olympic silver medalist Ryan Bailey and Bas Rutten- Inside MMA host and UFC champion fighter. Rajesh Khanna, MD has been featured on the front cover of various magazines like Your Health Connection, Life after 50, Valley news and Beverly Hills times. He has also been featured in Santa Monica Star, Acorn, India West, Opinion Express and numerous other publications. Dr. Khanna has been interviewed and quoted by various radio talk shows. He is one the pioneers of Lasik eye surgery and is currently at the forefront for advanced eye procedures. He is an experienced and skilled Wave front LASIK, Intacs, PRELEX and cataract surgeon, Dr. Khanna has performed over thousands of vision correction procedures.

###

Read the full story at http://www.prweb.com/releases/2010/crystalenscataract/prweb4067234.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible
2. MRI Partners with Natural Marketing Institute
3. Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting
4. Institute for Healthcare Advancement's Ninth Annual Health Literacy Conference Set for May 6-7, 2010 in Irvine, Calif.
5. Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers
6. The Colorado Institute for Drug, Device and Diagnostic Development Launches With a Statewide Call for Proposals From Life Science Technologies in Need of Funding and Active Management
7. Karmanos Cancer Institute in Detroit Names Gerold Bepler, M.D., Ph.D., as CEO
8. NASA selects DNA Medicine Institutes Nanoscale Diagnostics Technology for Phase II SBIR
9. The Andrews Institute and Reebok Join Partner Roster for USA Football's “Team USA vs. The World” Game, Presented By Riddell
10. Purchasing Director at The Icebox Appointed to Advertising Specialty Institute Leadership Advisory Board
11. The Institute of Women's Health of North America to Offer Free Chlamydia Testing at All Affiliated Campuses – Dr. Abdul Rao
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... Mass. , Dec. 8, 2016  EIP ... it has obtained proof-of-mechanism for neflamapimod (previously code ... completed Phase 2a clinical trials that demonstrated significant ... Study 302 (12-week treatment) and Study 303 (6-week ... Clinical Trials in Alzheimer,s Disease (CTAD) scientific conference ...
(Date:12/8/2016)... , Dec. 8, 2016 A Small ... the National Institutes of Health (NIH) to ... University.  The grant will seek to ... head device, which utilizes electromagnetic waves to treat Alzheimer,s ... this novel technology to possibly treat other neurologic disorders ...
Breaking Medicine Technology: